Nocturia in adults
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
Initial tests
In the practice
- Urine dipstick (glycosuria, haematuria, leucocyturia)
- 72-hour voiding diary: bedtime and waking time, each void with its volume, first morning void, fluid intake.
Laboratory tests
- Fasting plasma glucose
- Serum creatinine with eGFR
- Serum calcium
- HbA1c (known diabetic)if neededKnown diabetes: poorly controlled diabetes causes 24-hour polyuria and nocturia [2,3]; HbA1c is reimbursed only for monitoring glycaemic control [4].
- Urine microscopy and culture (if dipstick positive)if neededDipstick positive for leucocytes or blood: looking for leucocyturia or haematuria is part of the tests for voiding disorders [2].
- Serum electrolytes (serum sodium) (if 24-hour polyuria, or before desmopressin)if needednon-French guideline24-hour polyuria (> 40 mL/kg) or planned desmopressin: serum sodium is among the tests to do according to clinical judgement, and it conditions desmopressin (no prescription if ≤ 130 mmol/L) [5].
- TSH (if signs of thyroid dysfunction)if needednon-French guidelineSigns of hyperthyroidism or profound hypothyroidism, which can increase urine volume [3]. The British primary care consensus documents (endocrine and neurological diseases) propose renal function, TSH, serum calcium and plasma glucose or HbA1c [3,6].
- Serum ferritin (if restless legs syndrome or periodic limb movements suspected)if needednon-French guidelineNocturnal awakenings from restless legs syndrome: iron deficiency or a ferritin below 50-75 µg/L is looked for and treated (cause to be sought, iron supplementation if needed) [7].
- NT-proBNP (if heart failure suspected)if needednon-French guidelineOedema, jugular venous distension or history suggestive of heart disease: heart failure is a cause of nocturnal polyuria; NT-proBNP, ECG and blood pressure, echocardiography if NT-proBNP is raised [8].
- Urine osmolality on morning urine, without drinking after 22 h (if persistent polyuria > 2.5 L/24 h)if needednon-French guidelinePolyuria above 2.5 L per 24 hours that persists despite fluid advice: a urine osmolality > 600 mOsm/kg on waking, with no fluids since 22 h and a normal serum sodium, rules out diabetes insipidus [3].
Do not order
Desmopressin: serum sodium before and after
Before treatment
- Serum electrolytes (sodium)
- Serum creatinine with eGFR
Between D3 and D7
- Serum electrolytes (sodium)
At 1 month
- Serum electrolytes (sodium)
Sources (13)
- van Dijk L, Kooij DG, Schellevis FG. Nocturia in the Dutch adult population. BJU Int. 2002;90(7):644-8.
- Haute Autorité de santé, Association française d'urologie. Bilans pré-thérapeutiques des troubles mictionnels de l'homme adulte : modalités et acteurs. Recommandation de bonne pratique, validée le 9 novembre 2023, mise à jour en avril 2024.
- Dawson S, Duncan L, Ahmed A, et al. Assessment and treatment of nocturia in endocrine disease in a primary care setting: systematic review and nominal group technique consensus. Eur Urol Focus. 2022;8(1):52-59.
- Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : acte 1577 (HbA1c) ; sous-chapitre 13-03 (urines).
- Everaert K, Hervé F, Bosch R, et al. International Continence Society consensus on the diagnosis and treatment of nocturia. Neurourol Urodyn. 2019;38(2):478-498.
- van Merode NAM, Dawson S, Coulthard EJ, et al. Assessment and treatment of nocturia in neurological disease in a primary care setting: systematic review and nominal group technique consensus. Eur Urol Focus. 2022;8(1):33-41.
- Papworth E, Dawson S, Henderson EJ, et al. Association of sleep disorders with nocturia: a systematic review and nominal group technique consensus on primary care assessment and treatment. Eur Urol Focus. 2022;8(1):42-51.
- Garcia Reyes PB, Butcher K, Cotterill N, et al. Implications of cardiovascular disease for assessment and treatment of nocturia in primary care: systematic review and nominal group technique consensus. Eur Urol Focus. 2022;8(1):26-32.
- Hashim H, Blanker MH, Drake MJ, et al. International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function. Neurourol Urodyn. 2019;38(2):499-508.
- Ridgway A, Cotterill N, Dawson S, et al. Nocturia and chronic kidney disease: systematic review and nominal group technique consensus on primary care assessment and treatment. Eur Urol Focus. 2022;8(1):18-25.
- National Institute for Health and Care Excellence (NICE). Lower urinary tract symptoms in men: management. Clinical guideline CG97, mai 2010, dernière mise à jour juin 2015 (recommandations 1.1.3 à 1.1.7 et 1.4.10).
- Getaneh FW, Sussman RD, Iglesia CB. Nocturia: Evaluation and Management. Am Fam Physician. 2025;111(6):515-523B.
- ANSM. Résumé des caractéristiques du produit MINIRIN 0,1 mg, comprimé, et MINIRINMELT 60, 120 et 240 microgrammes, lyophilisat oral (desmopressine), rubriques 4.1 à 4.5. Base de données publique des médicaments (CIS 62822682 et 67275313), consultée le 12/10/2026 ; RCP mis à jour le 07/08/2026.